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Summary Unsaturated fatty acids, including n-3 polyunsaturated fatty acids (PUFAs) such as docosahexaenoic acid (C225, DHA) and
eicosapentaenoic acid (C20.5, EPA), and a series of n-6 PUFAs were investigated for their anti-tumour and antimetastatic effects in a
subcutaneous (s.c.) implanted highly metastatic colon carcinoma 26 (Co 26Lu) model. EPA and DHA exerted significant inhibitory effects on
tumour growth at the implantation site and significantly decreased the numbers of lung metastatic nodules. Oleic acid also significantly
inhibited lung metastatic nodules. Treatment with arachidonic acid showed a tendency for reduction in colonization. However, treatment with
high doses of fatty acids, especially linoleic acid, increased the numbers of lung metastatic nodules. DHA and EPA only inhibited lung
colonizations when administered together with the tumour cells, suggesting that their incorporation is necessary for an influence to be
exerted. Chromatography confirmed that contents of fatty acids in both tumour tissues and plasma were indeed affected by the treatments.
Tumour cells pretreated with fatty acids in vivo, in particular DHA, also showed a low potential for lung colony formation when transferred to
new hosts. Thus, DHA treatment exerted marked antimetastatic activity associated with pronounced change in the fatty acid component of
tumour cells. The results indicate that uptake of DHA into tumour cells results in altered tumour cell membrane characteristics and a
decreased ability to metastasize.
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As tumour metastasis exerts an adverse influence on the prognosis
of patients and is a major cause of cancer death, a considerable
number ofinvestigations into its biological, molecular and genetic
features have been conducted (Raz and Ben-Ze'ev, 1987;
Bertomeu et al, 1993). These investigations have indicated that
tumour metastases are established by an inter-related sequence of
processes, depending on various factors derived from both the
tumour and the host. There is substantial evidence that the
membrane properties oftumour cells play a majorrole in the inter-
actions between themselves and the surrounding environment
(Awad and Spector, 1976; Schroeder, 1984; Taraboletti et al, 1989;
Dahiya et al, 1992). Studies on mice have revealed that plasma
membranes of tumour sublines with high metastatic ability exhibit
a more fluid state than those with low metastatic ability, based on
differences in lipid composition and lipid-protein ratios (Kier
and Franklin, 1991). Furthermore, studies have demonstrated that
the chemical and physical properties of cell membranes are
modified by both the amount and type of fat in the diet, and this
influences growth and/or alters the metastatic ability of tumour
cells (Chen et al, 1992; Rose and Hatala, 1994). Diets rich in
linoleic acid have been found to enhance the growth and meta-
stasis of transplantable mammary carcinomas in rodents (Rao and
Abraham, 1976; Rose et al, 1993). In a study ofdietary n-3 PUFAs
in a spontaneous model of mammary adenocarcinoma in rats,
growth of primary tumours was significantly inhibited whereas
there was no effect on metastasis (Kort et al, 1987). In another
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study ofhuman breast cancer in the athymic nude mouse, high-fat
diets rich in n-3 fatty acid suppressed both growth and metastasis
(Rose and Connolly, 1993). In the described case, however, natural
fats were mixed into the experimental diet as the source ofPUFAs,
and it was uncertain whether the effects of the experimental diets
were linked to the main fatty acids and/or to the oxidized products
of PUFAs yielded before the administration. The objective of the
present study was to compare different PUFAs for their influence
on the metastatic ability ofcolon carcinoma 26 (Co 26Lu) tumour,
the highly metastatic murine colon carcinoma cell line that we
recently established (ligo et al, 1994), and to investigate the under-
lying mechanisms. For this purpose, we used highly purified
PUFAs and took strict precautions against fatty acid oxidation
before administration.
MATERIALS AND METHODS
Chemicals
Ethyl esters of9,12-octadecadienoic acid (linoleic acid),5,8,11,14-
eicosatetraenoic acid (arachidonic acid), 5,8,11,14,17-eicosapen-
taenoic acid (EPA) and 4,7,10,13,16,19-docosahexaenoic acid
(DHA) were obtained by preparative-scale high-performance
liquid chromatography and analysed for purity (more than 98%)
by capillary gas-liquid chromatography at Sagami Chemical
Research Center (Kanagawa, Japan). No antioxidants were added
to these fatty acid preparations, which were stored in sealed
ampoules (15 ml each) containing nitrogen gas at -20°C in the
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Table 1 Compositional analysis of AIN-93M(c) and AIN-93M diets
Fatty acids(%)
16:0 18:0 18:1 18:1 18:2 20:4 20:5 22:6 Others
n-9 n-7 n-6 n-6 n-3 n-3
AIN-93M(c) 12.4 4.4 42.0 2.2 17.1 0.0 0.0 0.0 21.9
AIN-93M 11.8 3.9 23.3 1.5 51.9 0.0 0.0 0.0 7.6
dark. The ethyl ester of 9-octadecenoic acid (oleic acid, 95%
purity) was obtained from Wako Chemicals, Tokyo, Japan.
Acetylsalicylic acid and indomethacin were purchased from Sigma
Chemical, St Louis, MO, USA.
Diets
The experimental basal diet used in this study, AIN-93M(c), was
prepared by Oriental Yeast, Tokyo,Japan, and is based on arevised
AIN-93M, replacing soybean oil with a coconut oil - rape seed oil
(60/40, w/w) blend to lower the content of linoleic acid without
changing the proportions of fat (4%), protein, vitamins, minerals
and fibre or the total calorific content. After receipt, the diets were
stored in a cold room at 4°C until use. The fatty acid compositions
of AIN-93M(c) and AIN-93M are shown in Table 1. The feeding
of AIN-93M(c) pellet diets to new CDF1 mice was commenced 7
days before implanting Co 26Lu cells. Once a week, a fresh diet
was provided, and any food not consumed was discarded. The rape
seed oil and the coconut oil used in the diet were ofresearch grade
and donated by NOF,Tokyo (Dr S Iwamoto).
Animals
Inbred, 4-week-old, CDF1 mice weighing approximately 18 g
each were obtained from Charles River Japan, Atsugi, Japan. The
animals were allowed free access to AIN-93M(c) pellet diets and
water and were maintained in plastic cages with woodchip
bedding under specific pathogen-free conditions in our animal
laboratory under controlled temperature (24 ± 2°C) conditions and
a 12-h light-dark cycle.
In vivo selection of a metastatic variant of Co 26 cells
The Co 26 line was maintained in vivo by serial s.c. transplantation
into male BALB/c mice. The original tumourcells demonstrated low
metastatic potential. Metastatic tumour cells (Co 26Lu) were
obtainedby repeated selection ofthelungcolonies formed,following
s.c. injection ofCo 26 cells, as reported previously (ligo et al, 1994).
Effects of fatty acids on lung colonization of
intravenously injected Co 26Lu cells
The Co 26Lu cell line was maintained in vivo by serial s.c. trans-
plantation into male BALB/c mice, which were fed on AIN-93M(c).
CDF1 (BALB/c x DBA/2) mice had more lung metastases than
BALB/c mice when Co 26Lu cells were implanted s.c. and hence
the CDF1 strain was used for this study. CDF1 mice at 5 weeks of
age were injected with Co 26Lu cells (3 x 104 per mouse) into the
tail vein on day 0 (seven mice per group), and0.1-ml aliquots ofthe
ethyl esters of oleic acid, linoleic acid, arachidonic acid, EPA and
DHA were administered p.o. daily for 5 days in three different
schedules: pretreatment (-day 7 to -day 3), simultaneous treat-
ment (-day 2 to +day 2) and post-treatment (+day 3 to +day 7).
Lung colonizations were counted on day 12.
Spontaneous metastasis model and treatment with
fatty acids
To investigate whether orally administered unsaturated fatty acids
modify tumour growth and/or metastatic ability ofthe tumour cells
to the lung, the following experiments were undertaken. CDF1
mice at 4 weeks old were given pellet diet AIN-93M(c) 7 days
before implantation of Co 26Lu cells. On day 0, 1 x 105 tumour
cells (0.1 ml) were implanted s.c. into the right thighs of mice,
which were then randomly allocated into control and treatment
groups (10-12 mice per group). The ethyl esters of oleic acid,
linoleic acid, arachidonic acid, EPA or DHA (0.1 and 0.2 ml) were
administered p.o. from day 5 for atotal of3 weeks (5 days per week
from Monday to Friday). The longest (a) and the shortest (b) diam-
eters ofthe tumour at the injection site were measured twice a week
using callipers, and the volume was calculated using the formula:
ab2/2 (mm3). All the mice that survived were killed on day 28. The
lungs were removed, rinsed in 0.9% sodium chloride solution
containing heparin and fixed for one day in acetone to allow deter-
mination ofthe numbers ofmacroscopic lung metastases.
Treatment with acetylsalicylic acid and indomethacin
To evaluate the additive effects of the anti-inflammatory agents
acetylsalicylic acid or indomethacin on the ability of PUFAs to
influence spontaneous lung metastasis, DHA and linoleic acid (0.1
ml per mouse) were administered p.o. daily from day 5 for 3 weeks
(5 days per week from Monday to Friday) and acetylsalicylic acid
(50 and 100 mg kg-') or indomethacin (5 and 10 mg kg-1) were
administered i.v. on days 10, 17 and 24 or orally five times a week
from days 5 to 27. All mice were killed on day 28 and investigated
for macroscopic lung metastases as described above.
Intravenous injection of tumour cells obtained from
mice treated with fatty acids
To assess directly the effects ofPUFAs on the metastatic ability of
Co 26Lu cells, tumour-bearing mice (five mice per group) were
administered daily either oleic acid, linoleic acid, EPA or DHA
(0.1 ml per mouse) from days 5 to 14 by gastric tube. They were
killed by cervical dislocation 24 h after the last treatment (day 15),
and their tumours were rapidly excised, minced with scissors,
pressed through 120 wire mesh using a pestle ofsyringe and saline
andfinally adjusted to 3 x l05 cells per ml. Five tissue preparations
were obtained for each fatty acid treatment group. The excised
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Table 2 Effects of various fatty acids on lung colonization by Co 26Lu
Fatty Acid Treatment Number of ling colonies
schedule Median (range)
1. Untreated control 22 (10-49)
Oleic acid -d7 to -d3 38 (27-57)
Linoleic acid -d7 to -d3 15 (10-55)
Arachidonic acid -d7 to -d3 25 ( 7-52)
EPA -d7 to-d3 26 (13-50)
DHA -d7to-d3 21 (12-36)
Oleic acid +d3 to +d7 37 (25-57)
Linoleic acid +d3 to +d7 28 ( 6-46)
Arachidonic acid +d3 to +d7 36 (15-44)
EPA +d3 to +d7 20 ( 7-53)
DHA +d3 to +d7 29 (22-44)
11. Untreated control 24 (12-51)
Oleic acid -d2 to +d2 12 ( 6-36)
Linoleic acid -d2 to +d2 16 ( 5-39)
Arachidonic acid -d2 to +d2 19 ( 5-30)
EPA -d2 to +d2 11a ( 4-22)
DHA -d2 to +d2 1a ( 3-22)
Co 26Lu cells (3 x 104 cells per mouse) were injected via the tail vein on day
0. Fatty acids were administered daily p.o. at 0.1 ml per mouse. On day 0,
fatty acids were administered p.o. 2 h before injection of tumour cells. Lung
colonies were counted on day 12. ap<0.05 compared with the untreated
control value.
tumour cells were then injected into the tail veins of three mice
(five x three mice per group), which were killed by cervical dislo-
cation 12 days thereafter for determination of the numbers of
macroscopic lung colonies.
Plasma and tumour samples for fatty acid analysis
To determine the fatty acids content in the plasma and tumour
tissues, tumour-bearing CDF1 mice (five mice per group) were
administered daily either oleic acid, linoleic acid, EPA or DHA
(0.1 ml per mouse) from days 5 to 14 by gastric tube. Blood
samples were collected under diethyl ether anaesthesia from the
descending vena cava at 24 h after the last administration of the
unsaturated fatty acids (day 15) and were immediately cooled on
ice. The samples were then centrifuged for 10 min at 3500 r.p.m.
and plasma was collected. Their tumours were removed and
chilled in dry ice-acetone as rapidly as possible.
Total lipids were extracted from the plasma and lyophilized
tumour tissue using a modification of a previously reported proce-
dure (Bligh and Dyer, 1959). For this purpose, approximately 10-
mg (dry weight) tissue samples were used. The lipids were
extracted with 1.5 ml of chloroform-methanol (1:2, v/v), and 0.5
ml each ofdistilled water followed by chloroform were added. The
residual lipids in the aqueous phase were extracted twice with 0.5
ml of chloroform. The extracts were pooled and evaporated to
dryness at 37°C under nitrogen.
Methyl esters of fatty acids were formed by adding 1 ml of
methanolic hydrochloric acid to the lipid extract in Teflon-coated
screw-capped culture tubes for 60 min at 100°C; they were then
extracted three times with n-hexane. The organic phase was evap-
orated under nitrogen, and the extracts were stored at -40C.
Residues were dissolved in 50 gl of n-hexane and the fatty acid
methyl esters were isolated by thin-layer chromatography
(TLC). TLC plate (no. 5721, Merck, Germany), developed with
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Figure 1 Effects of EPA and DHA on tumour growth of Co 26Lu cells
implanted s.c. into the right thighs of CDF1 mice. EPA and DHA were
administered p.o. five times a week. ( = doses of fatty acids, ml per mouse.
Each point represents mean ± s.e. (ten mice per group). *P<0.05, **P<0.01
compared with untreated control
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Figure 2 Effects of linoleic acid, EPA and DHA on body weight of CDF1
mice. Linoleic acid (0.2 ml, 0), EPA (0.2 ml, *) and DHA (0.1 ml, A; 0.2 ml,
A) were administered p.o. five times a week from day 5. Each point
represents mean ± s.e. (ten mice per group). **P<0.01 compared with
untreated control (0)
n-hexane-diethyl ether-acetic acid (80:20:1, v/v/v) and rendered
visible with Primurin (Sigma) solution to locate their positions for
further extraction with n-hexane.
Gas-liquid chromatography (GLC)
GLC of plasma and tumour samples was performed on a gaschro-
matograph (Shimadzu GC-9A, Shimadzu Seisakusho,Kyoto,Japan)
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Table 3 Preventive effect of pretreatment with unsaturated fatty acids on
metastatic potential of Co 26Lu cells
Fatty acid Median no. of lung colonies (range)
Untreated control 184 (150-245)
Linoleic acid 114a (69-167)
EPA 106a(76-156)
DHA 47b (36-53)
Co 26Lu tumour cells were implanted s.c. into CDF1 mice and fatty acids
were administered p.o. at 0.1 ml per mouse daily from days 5 to 15. Co 26Lu
cells (1 x 105 cells per mouse) from five different tumours per group were
injected into the tail veins of three new mice. Lung colonies were counted on
day 12. ap<0.05 compared with untreated control. bP<0.01 compared with
untreated control, linoleic acid and EPA.
Figure 3 Effects of various unsaturated fatty acids on lung metastatic
nodules in s.c. Co 26Lu-bearing mice. Co 26Lu cells (1 x 105 cells per
mouse) were implanted s.c. on the right thighs of mice on day 0. Fatty acids
were administered p.o. five times a week from day 5. The numbers of lung
metastatic nodules were determined on day 28. Bars with figures represent
the median number of metastases obtained from two experiments. ( ),
Number of mice. **P<0.01, ***P<0.001 compared with the untreated control
equipped with a flame ionization detector (splitting ratio 40:1)
and a computer-interfaced integrator (Chromatopack-CR6A,
Shimadzu). The column was a 25 m x 0.5 mm. The fused silica
(capillary stationary phase) was CP Wax 52 (Chrompack,
Middleburg, The Netherlands) with a 0.25-gm film thickness.
Nitrogen was used as the carrier and make-up gas and the column
flow rate was 1.2 ml min-'. The injection inlet and detector
temperature was 250°C. The oven temperature was programmed
as follows: the initial temperature of 180°C was maintained for 1
min; then increased to 1900C at the rate of 1°C min-' and held
there for 2 min; then increased to 210°C at 50C min-' and held
there for 9 min; then increased to 228°C at 6°C min- and then held
there for 4 min; the final temperature of 240°C was obtained by a
rise of 7°C min-' and was maintained for 3 min.
Integrated peak areas were used to calculate the percentages of
the various esters in each of the 24 fractions. Fatty acid methyl
esters were provisionally identified by co-chromatography with
authentic commercial fatty acid methyl ester standards.
Statistics
Data for tumour volume and fatty acid composition were statis-
tically evaluated using the Dunnett modification of the Student's
t-test. Number of lung metastases data were analysed using the
Mann-Whitney U-test.
RESULTS
Effects of fatty acids on lung colonization of
intravenously injected Co 26Lu cells
Co 26Lu cells were injected into the tail vein on day 0 and lung
colonies were counted on day 12. EPA and DHA significantly
decreased lung colonizations of Co 26Lu cells when fatty acids
were administered from -day 2 to +day 2 (Table 2). There was no
significant diminution of lung colonization with either pre- (-day
7 to -day 3) or post- (+day 3 to +day 7) treatment with fatty acids.
Effects of fatty acids on spontaneous metastases of Co
26Lu to the lung
Orally administered EPA and DHA caused significant retardation
of tumour growth of s.c. implanted Co 26Lu, especially when
administered at 0.2 ml per mouse (Figure 1). However, linoleic
acid did not exert any inhibitory influence, even at the high dose
(data not shown). In general, daily PUFA doses of 0.2 ml per
mouse were associated with loss of body weights, indicative of
transient toxicity to the host. However, recover of body weight to
the untreated control level was observed during treatment with
PUFAs (Figure 2).
When s.c.-implanted tumour volumes were 100 mm3 and over,
100% of the animals had microscopic lung metastases. The inci-
dences ofgrossly visible lung metastatic nodules, which were found
in all mice on day 28 in the untreated control group, were also
significantly decreased in the groups administered n-3 PUFAs, EPA
and in particular DHA (Figure 3). No inhibition of lung metastasis
was found at a dose of0.05 ml per mouse ofDHA (data not shown),
and administration of 0.2 ml per mouse resulted in a diminished
inhibitory effect on the formation of metastatic nodules in the lung.
Arachidonic acid demonstrated a tendency to decrease the number
of metastatic nodules in the lung. On the other hand, linoleic acid at
a daily dose of0.2 ml per mouse promoted metastasis.
Effects of acetylsalicylic acid and indomethacin on
lung metastasis
DHA is known to inhibit cyclo-oxygenase activity (Corey et al,
1983). The effects of the cyclo-oxygenase inhibitors, acetylsali-
cylic acid and indomethacin, were therefore investigated.
Indomethacin (1 mg kg-' i.p.) and acetylsalicylic acid (100 mg kg-'
i.p.) decrease prostaglandin levels in mice (Gupta, 1989). No
significant influence on the formation of metastatic nodules in the
lung was observed with either ofthe agents alone (data not shown)
or together with linoleic acid or DHA (median number of lung
metastatic nodules - untreated control, 35; acetylsalicylic acid 100
mg kg-' i.v., 29; linoleic acid, 39; DHA, 14.5; linoleic acid +
acetylsalicylic acid, 29.5; DHA + acetylsalicylic acid, 26).
Lung colonization after intravenous injection of Co
26Lu cells obtained from mice administered fatty acids
As shown in Table 3, tumour cells obtained after exposure to
DHA, EPA or linoleic acid demonstrated decreased numbers of
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Table 4 Fatty acid composition in the plasma after treatment of Co 26Lu-bearing mice with various fatty acids
Fatty acids Total (gg ml-1) Fatty acid composition (%, mean±s.e.)
16:0 18:0 18:1 18:1 18:2 18:3 20:4 20:5 22:6
n-9 n-7 n-6 n-6 n-3 n-3
Untreated 11 374 21.4+0.8 8.1 ±0.1 22.4±0.5 3.7±0.1 15.8±0.4 0.4±0.1 10.6±0.1 0.5±0.1 6.3±0.2
Oleic acid 4195 21.1 ±0.9 8.6+ 0.6 32.2± 1.Sa 4.2+ 0.3 12.0 ± 0.5 0.2± 0.0 7.7 0.9 0.3± 0.1 4.9± 0.5
Linoleic acid 3326 19.5 ±0.8 9.8± 1.1 16.5 1.1a 2.0 ± 0.1a 25.3±2.2a 0.2± 0.0 14.3 1.Ob 0.2± 0.0 4.6± 0.5
Arachidonic acid 4569 17.4 0.5a 7.9± 0.2 18.4 1.3 1.3± 0.1a 6.1 ±0.3a 0.2± 0.1 35.7± 1.4a 0.1 ± 0.0 3.8± 0.3
EPA 5342 21.0 1.1 7.9 ± 0.2 20.3 1.1 1.8 ± 0.1a 10.6 0.6a 0.3± 0.2 3.1 ± 0.2a 13.9± 1.7a 11.1 ± 0.8a
DHA 5094 21.2 0.9 7.0 ± 0.2 21.4 0.7 1.6± 0.1a 11.0 0.5b 0.6± 0.0 2.8± 0.3a 2.9± 0.2 24.3± 1.7a
Tumour-bearing mice (five mice per group) were treated with unsaturated fatty acids (0.1 ml per mouse) orally once a day for ten consecutive days from day 5.
Blood was taken from mice anaesthetized with ethyl ether 24 h after last treatment. The plasma was separated by centrifugation, and the samples were
assayed for fatty acids by gas chromatography. aP<0.01 compared with untreated control group; bp<0.05 compared with untreated control group. Italic indicates
correspondence with the administered fatty acid.
Table 5 Fatty acid levels in Co 26Lu tumour tissue after treatment of Co 26Lu-bearing mice with various fatty acids
Fatty acids Total (mg g-1) Fatty acid composition (%, mean±s.e.)
16:0 18:0 18:1 18:1 18:2 18:3 20:4 20:5 22:6
n-9 f-7 n-6 n-6 n-3 n-3
Untreated 255.4 22.0 0.4 6.1 ± 1.0 39.3± 1.4 3.9 0.2 7.8± 0.4 0.4± 0.1 3.3± 0.7 0.1 ± 0.1 1.6± 0.5
Oleic acid 164.4 17.6 0.8a 6.9 ± 1.1 40.0± 3.7 4.6 0.2b 7.1 ± 0.2 0.3± 0.1 5.5± 1.6 0.1 ± 0.1 3.0± 0.8
Linoleic acid 231.6 21.6+0.4 5.4 ± 0.6 38.8± 2.1 3.1 +0.2 12.4± 1.7a 0.3 ±0.0 3.1 +0.7 0.0 1.0± 0.2
Arachidonic acid 198.8 21.3 0.5 6.5 ± 0.9 39.4 ± 2.9 3.4 0.1 5.9± 0.3 0.3± 0.0 6.1± 1.4 0.0 1.1 ± 0.3
EPA 245.5 23.2 0.4 8.7 ± 1.9 32.3 ± 4.2 3.2+0.1 5.8± 0.2 0.3± 0.0 2.2± 0.5 1.7±O.la 3.9± 1.Ob
DHA 137.0 24.1 ±0.5 5.7 ± 0.3 40.4 ± 1.3 3.0 0.1 5.5± 0.2 0.3± 0.0 1.2± 0.1 0.3± 0.1 4.3± 0.5b
Tumour-bearing mice (five mice per group) were treated with unsaturated fatty acids orally once a day for ten consecutive days from day 5. The tumours were
taken from tumour-bearing mice 24 h after last treatment and were immediately frozen; the samples were then assayed for fatty acids by gas chromatography.
aP<0.01 compared with untreated control group;bp<Q.05 compared with untreated control group. Italic indicates correspondence with the administered fatty
acid.
lung colonies compared with their untreated counterparts. In
particular, tumour cells treated with DHA showed a marked
decrease in their lung colony-forming ability (P<0.01) compared
with those exposed to EPA or linoleic acid.
Changes in fatty acid contents in plasma and tumour
tissue following oral administration of PUFA
As shown in Table 4, oral administration ofunsaturated fatty acids
produced a decrease in the total fatty acids in the plasma. The
arachidonic acid contents increased following administration of
either arachidonic acid or linoleic acid and decreased following
administration ofoleic acid, EPA or DHA. Administration ofEPA
or DHA also caused elevations of their contents. In addition, a
slight increase in EPA was observed following DHA administra-
tion, and a slight decrease in DHA was noted following linoleic
acid and arachidonic acid administration.
In Co 26Lu tumour tissue (Table 5), total fatty acids did not
change markedly except after DHA and oleic acid administration.
Oleic acid constituted 40% of the total fatty acids. Arachidonic
acid contents were low, following the administration ofDHA. The
EPA contents were very low, except after administration of EPA
and DHA. DHA increased following administration of EPA and
DHA. Accordingly, administration ofunsaturated fatty acid altered
the contents offatty acids in tumour tissues. In particular, exposure
to DHA caused marked changes in constituents.
DISCUSSION
EPA and DHA did not show any inhibition of tumour growth and
metastases in animals fed a normal diet rich in linoleic acid. In this
study, using the AIN93M(c) diet, in which linoleic acid content
was markedly reduced, DHA and EPA, especially at high doses,
significantly inhibited the growth of the highly metastatic colon
carcinoma Co 26Lu, as well as lowering the numbers of lung
metastatic colonies. On the other hand, linoleic acid exerted an
enhancing effect on metastasis at high doses.
Mammary tumour cells with a high capacity for metastasis have
been reported to contain elevated levels ofprostaglandins compared
with their poorly metastatic counterparts (Fulton and Heppner,
1985). The eicosanoid content of tissues may clearly be influenced
by the fatty acid constituents of the dietary fats consumed by the
host animal. Linoleic acid and n-6 PUFAs are major sources of
arachidonic acid, which is further metabolized to prostaglandins
and leukotrienes by reactions catalysed by cyclo-oxygenase and
lipoxygenase respectively. While DHA is known to inhibit cyclo-
oxygenase activity (Corey et al, 1983), the failure in the present
study of acetylsalicylic acid and indomethacin, which reduce
prostaglandin levels (Gupta, 1989), to inhibit the formation of lung
metastatic nodules, either alone or following administration of
linoleic acid or DHA, suggests that the inhibition of metastasis
observed forfatty acids is notdependent on their influence on produc-
tion ofprostaglandins. In addition, administration ofarachidonic acid
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itselfdid not result in any enhancing effect on metastasis to the lung,
despite the increase in this n-6 fatty acid in tumourtissue. The results
thus indicate that prostaglandin content does not correlate with
formation ofmetastatic nodules in this tumour system.
The effects ofPUFAs have been shown to be selective for cancer
cells without affecting normal cells in vitro (Begin et al, 1986).
EPA, in particular, has been reported to significantly inhibit the
growth of human pancreatic cancer cell lines in vitro (Falconer et
al, 1994), and this effect appears to be associated with the genera-
tion oflipid peroxides (Begin et al, 1985). In Co 26Lu culture cells
in RPMI-1640 containing 10% fetal bovine serum (FBS), IC50
values for treatment with EPA and DHA were all about 50 l.M,
whereas values for oleic acid and linoleic acid were over 100 ltM
after 6 days' exposure. There were no large differences between
EPA and DHA. In our in vivo study, oral administration of EPA
and DHA before or after the injection of tumour cells into a tail
vein did not significantly inhibit lung colonization so that a simul-
taneous presence appears to be of importance. Incorporation of
EPA and DHA may yield lipid peroxides, which can kill the
tumour cells. However, the effect of oleic acid cannot be simply
explained by the same mechanism and requires further investigation.
The ability of tumour cells to metastasize has been shown to
depend on the fatty acid composition ofthe cell membrane and reflect
the dietary fat intake (Cave and Erickson-Lucas, 1982; Cohen et al,
1986). Cells are modified by the fatty acid constituents of the culture
medium in vitro (Wicha et al, 1979; Ginsberg et al, 1982), and
membranes rich in linoleic acid exhibit high fluidity (Ginsberg et al,
1982; Taraboletti et al, 1989). In murine tumour cell lines, a relation-
ship exists between metastatic ability and the lipid composition ofthe
cell membrane, with linoleic acid playing an important role (Kier and
Franklin, 1991). Different contents ofoleic acid and arachidonic acid
have been noted between primary and metastatic tumours (Kier et al,
1988). In metastatic variants ofa series ofhuman prostatic adenocar-
cinoma cell lines, the arachidonic acid level was found to be signifi-
cantly decreased (Dahiya et al, 1992). However, in our study, tumour
cells obtained from the hosts administered EPA orDHAdemonstrated
decreases in both arachidonic acid contents and metastatic ability.
Moreover, i.v. injection of tumour cells with a greatly increased
content oflinoleic aciddid notresult in any increase inlung metastatic
nodules. Administration of large amounts of fatty acids (0.2 ml)
caused toxicity, and this was associated with some reduction in the
inhibitory effects on lung metastatic nodules, presumably owing to an
impaired host defence system, such as inhibition ofmacrophage acti-
vation by DHA (Dustin et al, 1990). In conclusion, the present data
suggest that fatty acid composition of tumour cell membrane is an
important factor with relevance to metastatic potential. An increase in
n-3 PUFAs, such as EPA and DHA, appears to reduce these features
of malignancy without necessarily blocking prostaglandin synthesis.
The present model should allow light to be cast on the mechanisms
underlying this beneficial influence.
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